Published on 19 May 2022 on Simply Wall St. via Yahoo Finance
EyePoint Pharmaceuticals (NASDAQ:EYPT) adds US$32m to market cap in the past 7 days, though...
This week we saw the EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) share price climb by 11%. But don't envy holders -- looking back over 5 years the returns have been really bad. Indeed, the share price is down 55% in the period. Some might say the recent bounce is to be expected after such a bad drop. Of course, this could be the start of a turnaround.
Although the past week has been more reassuring for shareholders, they're still in the red over the last five years, so let's see if the underlying business has been responsible for the decline.
See our latest analysis for EyePoint Pharmaceuticals